PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
33431610-0	2021	Safety, Pharmacokinetic and Pharmacodynamic Evaluation of a 2"-MOE Antisense Oligonucleotide-GalNAc3 Conjugate that Targets the Human Transmembrane Protease Serine 6 (TMPRSS6).	galnac3	93-100	transmembrane serine protease 6	Homo sapiens	134-165	
33431610-0	2021	Safety, Pharmacokinetic and Pharmacodynamic Evaluation of a 2"-MOE Antisense Oligonucleotide-GalNAc3 Conjugate that Targets the Human Transmembrane Protease Serine 6 (TMPRSS6).	galnac3	93-100	transmembrane serine protease 6	Homo sapiens	167-174	
33431610-4	2021	ISIS 702843 is a GalNAc3-conjugated 2"-MOE ASO specific for human transmembrane protease, serine 6 (TMPRSS6), and is currently in clinical trials for the treatment of beta-thalassemia.	galnac3	17-24	transmembrane serine protease 6	Homo sapiens	66-98	
33431610-4	2021	ISIS 702843 is a GalNAc3-conjugated 2"-MOE ASO specific for human transmembrane protease, serine 6 (TMPRSS6), and is currently in clinical trials for the treatment of beta-thalassemia.	galnac3	17-24	transmembrane serine protease 6	Homo sapiens	100-107